StonvexLoading…
StonvexStonvexStonvexCore line items from IBKR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.44B | $1.98B | $1.56B | $1.51B |
Operating Income | $4.77B | $3.69B | $3.07B | $2.00B |
Net Income | $4.36B | $3.41B | $2.81B | $1.84B |
EPS (Diluted) | $2.22 | $1.73 | $1.42 | $3.75 |
Total Assets | $203.24B | $150.14B | $128.25B | $115.14B |
Total Liabilities | $182.77B | $133.54B | $114.18B | $103.53B |
Cash & Equivalents | $4.96B | $3.63B | $3.75B | $3.44B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 443.86M | 436.01M | 423.39M | 101.30M |